HTT and Huntington disease: In contrast to the cases of tau and synuclein, phosphorylation of mutant huntingtin (Htt) at Ser 421 in response to IGF treatment reduced toxicity [9]; similarly, phosphorylation of Htt at Ser 13 and 16 alleviated phenotype in a mouse model of HD [10].